Literature DB >> 25219107

Short-term effects of airborne ragweed pollen on clinical symptoms of hay fever in a panel of 30 patients.

D Caillaud, M Thibaudon, S Martin, C Ségala, J P Besancenot, B Clot, H François.   

Abstract

OBJECTIVES: Ragweed, Ambrosia artemisiifolia, is a highly allergenic annual herbaceous plant that is spreading quickly across the globe. Few studies have investigated the relationship between ragweed pollen counts and hay fever symptoms. We investigate the dose-response relationship between ragweed exposure in patients sensitized to ragweed and daily hay fever symptoms.
METHOD: A panel study was conducted among 31 adult patients sensitized to A artemisiifolia in France and Switzerland. Rhinitis, conjunctivitis, and bronchial symptoms were recorded daily, as well as daily pollen counts of ragweed, air pollutants, and meteorological data over 2 successive years. Data were analyzed with generalized estimating equation models to quantify effects of ragweed pollen whilst controlling for confounders.
RESULTS: The relationship between ragweed pollen and the percentage of patients with nasal, ocular, and bronchial symptoms was linear. For every increase of 10 grains/m3, the odds ratio (OR) (95% confidence interval) for nasal symptoms was, in 2009, 1.18 [1.04-1.35] on weekdays and 1.43 [1.16-1.75] at weekends, and in 2010, 1.04 [1.00-1.07] on weekdays and 1.25 [1.06-1.46] at weekends.The OR for ocular symptoms was 1.32 [1.16-1.56] in 2009 and 1.05 [1.02-1.07] in 2010. Finally, the OR for bronchial symptoms was 1.14 [1.03-1.25] in 2009 and 1.03 [0.97-1.08] in 2010.
CONCLUSION: There is a statistically significant linear relationship between ragweed pollen counts and hay fever symptoms. Our study shows that nasal symptoms differ on weekdays and at weekends.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25219107

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  7 in total

Review 1.  Vaccine development and new attempts of treatment for ragweed allergy.

Authors:  David El-Qutob
Journal:  Ther Adv Vaccines       Date:  2015-03

Review 2.  A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).

Authors:  Mirjana Turkalj; Ivana Banic; Srdjan Ante Anzic
Journal:  Patient Prefer Adherence       Date:  2017-02-14       Impact factor: 2.711

3.  Modifiable Risk Factors for Common Ragweed (Ambrosia artemisiifolia) Allergy and Disease in Children: A Case-Control Study.

Authors:  Maureen Agnew; Ivana Banic; Iain R Lake; Clare Goodess; Carlota M Grossi; Natalia R Jones; Davor Plavec; Michelle Epstein; Mirjana Turkalj
Journal:  Int J Environ Res Public Health       Date:  2018-06-26       Impact factor: 3.390

4.  Short-term exposure to pollen and the risk of allergic and asthmatic manifestations: a systematic review and meta-analysis.

Authors:  Milja A Kitinoja; Timo T Hugg; Nazeeba Siddika; Daniel Rodriguez Yanez; Maritta S Jaakkola; Jouni J K Jaakkola
Journal:  BMJ Open       Date:  2020-01-10       Impact factor: 2.692

5.  Interactive effects of allergens and air pollution on respiratory health: A systematic review.

Authors:  Holly C Y Lam; Deborah Jarvis; Elaine Fuertes
Journal:  Sci Total Environ       Date:  2020-12-04       Impact factor: 7.963

6.  Ragweed pollen concentration predicts seasonal rhino-conjunctivitis and asthma severity in patients allergic to ragweed.

Authors:  Maira Bonini; Gianna Serafina Monti; Matteo Maria Pelagatti; Valentina Ceriotti; Elisabetta Elena Re; Barbara Bramè; Paolo Bottero; Anna Tosi; Adriano Vaghi; Alberto Martelli; Giovanni Maria Traina; Loredana Rivolta; Federica Rivolta; Claudio Maria Ortolani
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

7.  Fine-Scale Exposure to Allergenic Pollen in the Urban Environment: Evaluation of Land Use Regression Approach.

Authors:  Jan Hjort; Timo T Hugg; Harri Antikainen; Jarmo Rusanen; Mikhail Sofiev; Jaakko Kukkonen; Maritta S Jaakkola; Jouni J K Jaakkola
Journal:  Environ Health Perspect       Date:  2015-10-09       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.